Journal of Obesity / 2011 / Article / Fig 4

Clinical Study

Perspectives of CB1 Antagonist in Treatment of Obesity: Experience of RIO-Asia

Figure 4

Effect of rimonabant on HDL-cholesterol, triglycerides, and waist circumference at each visit and at 9 months.
957268.fig.004a
(a)
957268.fig.004b
(b)
957268.fig.004c
(c)

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.